← Back

Procter & Gamble: P&G's Fiscal '25 Results: A Strong Foundation for Future Growth

P&G's fiscal '25 organic sales grew 2%, driven by 1 point from volume and 1 point from price/mix, with 9 out of 10 product categories reporting growth. Core EPS came in at $6.83, up 4% for the year, beating analyst estimates. In Q4, organic sales grew 2%, with 6 of 7 regions holding or growing organic sales. Core EPS was $1.48, up 6% versus the prior year, with the actual EPS beating estimates of $1.42. The company's adjusted free cash flow productivity was 87%, and it returned $16 billion to shareholders through dividends and share repurchases.

PG

USD 143.1

-0.69%

A-Score: 5.4/10

Publication date: July 29, 2025

Author: Analystock.ai

πŸ“‹ Highlights
  • Leadership Transition - Jon Moeller to become Executive Chairman, Shailesh Jejurikar to take over as President and CEO in January.
  • Organic Sales Growth - Fiscal '25 organic sales grew 2% with 1% from volume and 1% from price/mix.
  • E-commerce Performance - E-commerce sales rose 12%, now representing 19% of total company sales.
  • Core EPS Growth - Core EPS increased 4% to $6.83, with adjusted free cash flow productivity at 87%.
  • Restructuring Program - A 2-year restructuring plan aims to reduce 7,000 non-manufacturing roles, about 15% of the workforce.

Segment Performance and E-commerce Growth

Nine of P&G's 10 product categories grew organic sales, with Family Care and Personal Health Care growing at single digits. E-commerce sales increased 12%, representing 19% of total company sales. The company's e-commerce growth is a significant contributor to its overall sales, and it continues to be a key area of focus. As Jon R. Moeller mentioned, "our portfolio is concentrated in daily use categories where performance drives brand choice and value."

Guidance and Outlook for Fiscal '26

For fiscal '26, P&G expects local currency value growth in the range of flat to 3%, with organic sales growth in line to up 4% versus the prior year. The guidance includes a 30-50 basis point headwind from brand and product form discontinuations. Core EPS growth is expected to be in line to plus 4% versus fiscal year '25, with a range of $6.83 to $7.09 per share. Analysts estimate next year's revenue growth at 3.2%, which is within the company's guidance range.

Valuation Metrics and What's Priced In

Using various valuation metrics, we can understand what's priced into P&G's stock. The company's P/E Ratio is 24.06, P/B Ratio is 7.35, and P/S Ratio is 4.36. Additionally, the EV/EBITDA ratio is 18.61, and the Dividend Yield is 2.63%. These metrics indicate that the market has a relatively positive outlook on the company's future growth prospects. The ROE is 30.78%, and ROIC is 16.51%, indicating a strong ability to generate returns on equity and invested capital.

Restructuring Program and Future Plans

P&G has announced a 2-year restructuring program aimed at strengthening its current strategy to widen its margin advantage. The program focuses on three main areas: portfolio, supply chain, and organization design. The company expects to reduce up to 7,000 non-manufacturing roles, roughly 15% of its current non-manufacturing workforce. The restructuring program is designed to build financial headroom to invest in innovation and commercialization.

Procter & Gamble's A-Score